市场调查报告书
商品编码
1218831
全球化合物管理市场:到2028预测—按类型(产品和服务),样本类型(生物样本和化合物),应用(基因合成,生物银行和药物发现),最终用户和地区进行分析Compound Management Market Forecasts to 2028 - Global Analysis By Type (Products and Services), Sample Type (Bio Samples and Chemical Compounds), Application(Gene Synthesis, Bio Banking and Drug Discovery), End User and By Geography |
根据 Stratistics MRC 的数据,全球复合管理市场规模将在 2022 年达到 4.3168 亿美元,到 2028 年达到 11.166 亿美元,预测期内復合年增长率为 16.8%。预计将增长在
化合物管理,也称为化合物管理,定义为化学品库的管理,包括更新过期化学品,包含信息的数据库,经常参与检索化学品的机器人以及存储环境的质量控制。 我们提供基础设施和物流来帮助管理您的研究化合物。 它支持新药的开发,包括药物发现过程中的化合物储存,製备,试验评估和分配等物流。
根据 Pharma R&D 年度回顾,2020 年在研产品由 17,737 项组成,现在已增加到 20,109 项。 根据 FDA 的建议,生物技术和製药公司在研发过程中严重依赖生物标誌物的发现和开发。
市场动态
驱动程序
技术进步
在復合管理领域引入人工智能和机器人技术等技术进步是市场增长的主要驱动力。 为了处理诸如从存储中添加和移除化合物样品等操作,大型製药公司正在机器人技术的帮助下自动化化合物管理流程,并通过电子条形码促进记录保存。。 这些因素促进了市场的增长。
抑製剂
投资巨大
复合管理要求仍然是一项重大挑战,但正在通过共同努力加以克服。 化合物管理设施需要大量资金用于硬件和软件,包括建造连接到大型库存数据库的新的自动化液体化合物存储系统。 因此,这些点正在抑制市场的增长。
机会
保持速度和准确性
有效的复合管理系统必须平衡速度和准确性。 大多数复合处理系统旨在减少造成大多数问题的人为干预。 机架,传送带和机械臂经常用于化合物存储和传输的自动化化合物备份和恢復系统。 因此,这些都是推动市场增长的因素。
威胁
低效的管理
不适当的化合物管理会在医疗保健研究领域导致各种不良后果。 化合物管理不当会导致样品丢失或变质,不必要的支出以及其他阻碍药物研发过程的瓶颈。 因此,这些因素阻碍了市场的扩大。
COVID-19 的影响
不同的医疗机构受到了 COVID-19 疫情的影响。 复合管理市场也产生了重大影响。 封锁扰乱了物流和运输。 技术进步,成本控制和改善可及性对于不久的将来的医疗改革至关重要。 前线是数字医疗和远程医疗。 此次疫情再次印证了远程诊疗和会诊的重要性。 然而,随着许多医护人员通过电话或视频会议工作,这一领域的增长将会增加。 对中度症状患者的在线咨询大大减轻了已经因患者人数不堪重负的医院的负担。
预计服务业在预测期内将成为最大的行业
由于药物发现活动的增加,对化合物管理服务的需求增加以及降低与药物发现相关的成本的需求增加,预计服务行业将实现利润丰厚的增长。 预计大量没有基础设施的中小企业也将进一步刺激需求,这可能对该领域的增长产生积极影响。
预计生物样本库行业在预测期内的复合年增长率最高
由于参与收集和存储生物材料的组织的增加,生物样本库行业预计在预测期内以最快的复合年增长率增长。 此外,对个性化医疗的日益重视增加了对生物样本库的需求。 此外,对用于支持研究的高质量生物样本的需求预计会增加。 因此,上述因素预期将支持该分部的增长。
市场份额最大的地区
由于区域政府举措,药物发现和公私合作等持续研究,预计亚太地区在预测期内将占据最大的市场份额。 此外,复合管理服务的低外包成本,慢性病和传染病的流行等正在推动研究需求并促进该地区的市场增长。
复合年增长率最高的地区
由于化合物管理外包的增加,人工智能在药物开发工作流程中的使用增加以及生物样本库的当前趋势,预计北美在预测期内的复合年增长率最高。 此外,与疾病相关的发病率和死亡率上升已经确定了更多的候选药物,促进了该地区的增长。
主要发展
2022 年 6 月,欧洲领先的技术和产品开发商 TTP 和下一代清洁能源离子交换膜和聚合物的设计者和製造商 Ionomr Innovations Inc. 设计了一种用于大规模生产的新型绿色氢。宣布他们将共同开展电解槽的示范工作。
2021 年 2 月,SPT Labtech 宣布收购机器人自动化供应商 BioMicroLab,以增强其在自动化样本管理方面的能力。
这份报告提供了什么
免费定制服务
订阅此报告的客户将免费获得以下自定义选项之一。
According to Stratistics MRC, the Global Compound Management Market is accounted for $431.68 million in 2022 and is expected to reach $1101.66 million by 2028 growing at a CAGR of 16.8% during the forecast period. Compound management, also referred to as compound control, is defined as the management of chemical libraries, including renewal of outdated chemicals, databases containing the information, robotics often involved in fetching chemicals, and quality control of the storage environment. It provides the infrastructure and logistics that aid in managing research compounds. It aids in the development of new drugs, and entails the logistics of storing, preparing, and evaluating compounds for testing as well as dispensing them during the drug discovery process.
According to Pharma R&D annual review, the pipeline consisted of 17,737 drugs in 2020, now the number of drugs in the pipeline rose to 20,109. According to FDA recommendations, biotechnology and pharmaceutical companies depend significantly on the discovery and development of biomarkers in R&D processes.
Market Dynamics:
Driver:
Technological Advancements
Technological advancements such as introduction of artificial intelligence and robotic technology in the field of compound management is a major factor driving the market growth. Large pharmaceutical companies automate compound management process with the help of robotics technology for handling the duties of adding and removing compound samples from storage and electronic barcodes facilitate record keeping. Hence, these are the factors fueling the growth of the market.
Restraint:
Huge Investments
The requirement for compound management presents significant problems, which are being overcome by coordinated efforts. A compound management facility requires significant financial outlays for both hardware and software, including the construction of new automated liquid compound storage systems connected to a substantial inventory database. Thus, these aspects are restraining the growth of the market.
Opportunity:
Maintaining speed and accuracy
An effective compound management system must strike a balance between speed and accuracy. Most compound handling systems aim to reduce human handling because it is the source of the vast majority of problems. Racks, carousels, and robotic arms are frequently used in automated compound backup and recovery systems to store and transfer compounds. Therefore, these are the factors boosting the market growth.
Threat:
Inefficient management
Improper compound management could potentially lead to various unfavourable consequences in the healthcare research sector. Inadequate compound management leads to loss or spoilage of samples, unwanted expenditure, and various other bottlenecks that hamper the drug research and development process. Hence, these factors are hindering the expansion of the market.
COVID-19 Impact
Various healthcare facilities were affected due to the outbreak of COVID-19. There was a huge impact on Compound Management Market as well. Lockdowns disrupted logistics and transportation. An integral part of healthcare reforms in near future will be technological progress, cost containment, and increased access. The front liners are digital health and telehealth. The importance of remote diagnosis, care, and consultation is re-emphasized due to the pandemic. However, many healthcare workers are working on telephone calls and video conferencing, this segment growth will increase. Online consultation of patients with moderate symptoms has greatly reduced the burden on hospitals already swamped by counts of the patients.
The service segment is expected to be the largest during the forecast period
The service segment is estimated to have a lucrative growth, due to the rise in drug discovery activities, the growing need to manage the compound management services, and the increasing need to save costs associated with drug discovery. A significant number of small and medium-sized companies lacking infrastructure is further expected to improve the demand and thus is likely to have a positive impact on the segment growth.
The bio banking segment is expected to have the highest CAGR during the forecast period
The bio banking segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increasing number of organizations involved in the collection and storage of biomaterials. In addition, an increasing emphasis on personalized medicine is driving the need for bio banking. Besides, the need for quality bio specimens that are used to support research is expected to increase. Thus, the abovementioned factors are anticipated to support the growth of the segment.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to continuous research in regional government initiatives, pharmaceutical discovery, and private-public collaborations. Furthermore, the low cost of outsourcing compound management services and the high prevalence of chronic and infectious diseases in the region are driving the demand for research, thus contributing to the regional market growth.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to rising outsourcing of compound management, increasing use of AI in drug development workflow, and the current trend of biobanking. Furthermore, the rise in disease-related morbidity and mortality has resulted in the identification of more drug candidates, fueling growth in this region.
Key players in the market
Some of the key players profiled in the Compound Management Market include BioAscent, Brooks Life Sciences, Hamilton Company, Titian Software Limited, LiCONiC AG, Evotec, Azenta US, Inc., Tecan Trading AG, Beckman Coulter, Inc, SPT Labtech LTD., AXXAM S.p.A., Labcyte , Biosero, Wuxi Apptec, TTP Group, Frontier Scientific and Icagen, Inc.
Key Developments:
In June 2022, TTP Europe's leading technology and product development company and Ionomr Innovations Inc., designer and manufacturer of next-generation ion-exchange membranes and polymers for clean energy, announced they are joining forces to demonstrate a new green hydrogen electrolyzer designed for mass production.
In February 2021, SPT Labtech announced the acquisition of BioMicroLab, a robotics automation provider, to strengthen its capabilities in automatic sample management.
Types Covered:
Sample Types Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: